Publication List English

2025/11/17
Narrative Review of Patient Cancer Tissue-Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical Application

2025/10/31
Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle-Invasive Bladder Cancer

2025/10/16
AI-Driven Image Analysis for Precision Screening Transposon-Mediated Transgenesis of NFƒΘB eGFP Reporter System in Zebrafish

2025/08/06
Variation and classification of chemically-induced zebrafish malformations for the ICH S5 (R3) guideline: an atlas for zebrafish teratogenesis

2024/08/06
Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline

tEffect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.

                     
1980/08/27

Endocrinol Jpn. 1980 Aug;27(4):447-50.

Effect of beta-adrenergic blockade on plasma dopamine-beta-hydroxylase activity and triiodothyronine in hyperthyroidism.
Tanaka T, Yamaguchi T, Kuma K, Hidaka H.
Endocrinol Jpn. 1980 Aug;27(4):447-50.

Abstract

The effect of propranolol on plasma dopamine-beta-hydroxylase activity and triiodothyronine was investigated in twelve subjects with Graves' disease. Plasma DBH activity, serum triiodothyronine and thyroxine were determined beforehand and electrocardiograms were recorded on the same days as the blood samples were taken. Propranolol administration was associated with clinical amelioration in blood pressure and ECG. There was a positive and significant correlation between changes in DBH activity and triiodothyronine caused by propranolol. These data offer evidence that there may be an interaction between plasma DBH activity and triiodothyronine during propranolol administration in hyperthyroidism.

ŠΦ˜AƒŠƒ“ƒN

Pubmed